{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:35:06Z","timestamp":1790116506867,"version":"4.0.1"},"reference-count":33,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T00:00:00Z","timestamp":1343174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background\u2002<\/jats:bold>\n                    The use of systemic steroids in the treatment of psoriasis is not recommended by dermatological textbooks and guidelines because of the risk of disease deterioration after dose reduction or withdrawal. In contrast to these recommendations, a recent analysis using data from a German nationwide healthcare insurance revealed that systemic steroids were the most frequently prescribed drugs for psoriasis by general practitioners, internal medicine physicians and dermatologists.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective\u2002<\/jats:bold>\n                    As there is an obvious discrepancy between the use of systemic steroids for psoriasis and the reported adverse effects, a non\u2010systematic literature search starting 1950 until today was performed to address beneficial and adverse effect of systemic steroids in psoriasis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods\u2002<\/jats:bold>\n                    Non\u2010systematic literature search.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results\u2002<\/jats:bold>\n                    Regarding the widespread use of systemic steroids in psoriasis and other medical conditions taking the high prevalence of psoriasis of 2\u20133% at least in Caucasians into consideration, there is a remarkable lack of literature addressing adverse effects such as rebound, pustular or erythrodermic flares or even new occurrence of psoriasis in patients with a negative disease history.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion\u2002<\/jats:bold>\n                    A re\u2010evaluation of the treatment of psoriasis and\/or psoriatic arthritis with systemic steroids is necessary.\n                  <\/jats:p>","DOI":"10.1111\/j.1468-3083.2012.04656.x","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T09:31:37Z","timestamp":1343208697000},"page":"1022-1025","source":"Crossref","is-referenced-by-count":49,"title":["Systemic steroids in the treatment of psoriasis: what is fact, what is fiction?"],"prefix":"10.1111","volume":"27","author":[{"given":"U.","family":"Mrowietz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Domm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,7,25]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"S1","article-title":"S3\u2010guidelines for the treatment of psoriasis vulgaris Update 2011","volume":"9","author":"Nast A","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03389.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2011.07713_suppl.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09348.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1968.tb11947.x"},{"key":"e_1_2_5_7_2","first-page":"415","article-title":"Generalized pustular psoriasis (von Zumbusch) following iatrogenic hypocortisolism. Induction of generalized pustular psoriasis by topical use of betamethasone\u2010dipropionate ointment in psoriasis","volume":"14","author":"Augey F","year":"2004","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_8_2","first-page":"317","article-title":"Induction of generalized pustular psoriasis by topical use of betamethasone\u2010dipropionate ointment in psoriasis","volume":"8","author":"Hellgren L","year":"1976","journal-title":"Ann Clin Res"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.1999.12.813"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1951.64"},{"key":"e_1_2_5_11_2","first-page":"189","article-title":"Some data on the influence of factors unrelated to therapy on the healing time in an attack of psoriasis","volume":"24","author":"Zaun H","year":"1973","journal-title":"Hautarzt"},{"key":"e_1_2_5_12_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2340\/0001555556139147","article-title":"Generalized pustular psoriasis. A report on thirteen patients","volume":"56","author":"Lindgren S","year":"1976","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_5_13_2","first-page":"13","article-title":"Oral glucocorticosteroid therapy in psoriasis vulgaris: pro and con","volume":"36","author":"Zaun H","year":"1985","journal-title":"Hautarzt"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1976.tb02274.x"},{"key":"e_1_2_5_15_2","first-page":"115","article-title":"New types of pustular psoriasis","volume":"26","author":"Agache P","year":"1970","journal-title":"Arch Belg Dermatol Syphiligr"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1961.tb14415.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1957.tb13225.x"},{"key":"e_1_2_5_18_2","first-page":"659","article-title":"The treatment of psoriasis and other dermatoses with triamcinolone (aristocort)","volume":"167","author":"Shelly WB","year":"1958","journal-title":"J Am Med Assoc"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(195912)2:6<513::AID-ART1780020606>3.0.CO;2-5"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000255518"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1960.44"},{"key":"e_1_2_5_22_2","first-page":"541","article-title":"Case of generalized pustular psoriasis caused by corticosteroid treatment of simple psoriasis and pemphigus","volume":"66","author":"Chowaniec O","year":"1979","journal-title":"Przegl Dermatol"},{"key":"e_1_2_5_23_2","first-page":"632","article-title":"Photochemotherapie bei kortikosteroid\u2010 und methotrexatbehandelten Psoriatikern","volume":"28","author":"Gschnait F","year":"1977","journal-title":"Hautarzt"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70287-5"},{"key":"e_1_2_5_25_2","first-page":"569","article-title":"Innere Behandlung der Psoriasis \u2013 Eine \u00dcbersicht","volume":"27","author":"Zachariae H","year":"1976","journal-title":"Hautarzt"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094946"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200350"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.021"},{"key":"e_1_2_5_29_2","first-page":"S85","article-title":"Adverse events of intravenous glucocorticoid pulse therapy in inflammatory diseases: a meta\u2010analysis","volume":"29","author":"Smits NA","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.100008"},{"key":"e_1_2_5_31_2","first-page":"611","article-title":"The potential role of hypocortisolism in the pathophysiology of PTSD and psoriasis","volume":"23","author":"Thaller V","year":"1999","journal-title":"Coll Antropol"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000315053"},{"key":"e_1_2_5_33_2","first-page":"103","article-title":"In etanercept\u2010treated psoriatic arthritis patients clinical improvement correlated with an increase of serum cortisol relative to other adrenal hormones","volume":"26","author":"Atzeni F","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.179"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2012.04656.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2012.04656.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T07:27:45Z","timestamp":1696231665000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2012.04656.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,25]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.1111\/j.1468-3083.2012.04656.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04656.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,25]]}}}